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Abstract Conflicting data exist about the effects of car-
diac resynchronization therapy (CRT) on diastolic function
(DF). Aim of the study was to assess if and how CRT
affects DF in systolic heart failure patients. We also
investigated potential relations between CRT-induced left
ventricular changes and the composite clinical endpoint of
progressive heart failure and cardiac death over 3 years
follow-up. 119 CRT patients underwent clinical evaluation
and echocardiography before CRT and 4 months later. DF
was quantified by transmitral velocities [E/A waves,
deceleration time (DT), E/DT], early diastolic mitral
annulus velocity (E0), E/E0 ratio and 2-D speckle tracking
strain rate during isovolumetric relaxation (IVR, SRivr).
End-diastolic pressure–volume relationship (EDPVR) was
also assessed noninvasively using a single-beat method.
Overall stiffness was quantified by ventricular stiffness
(Klv) normalized to end-diastolic volume (EDV). New
York Heart Association class improved at 4 months (from
2.7 ± 0.7 to 1.9 ± 0.6, p \ 0.001) as did ventricular filling
(E/DT from 0.48 ± 0.29 to 0.39 ± 0.31 cm/s2, p = 0.01).
In contrast, relaxation (E0, SRivr) and filling pressures (E/E0,
E/SRivr) did not change. Slope of EDPVR did not change
with CRT. Such finding, together with an unmodified
Klv/EDV and a 7 ± 18 % reduction in EDV (p = 0.001),
suggested reverse remodelling towards a smaller equilib-
rium volume. Finally, end-systolic LV volume decreased
from 147 ± 59 to 125 ± 52 ml and ejection fraction
increased from 0.26 ± 0.07 to 0.32 ± 0.09 (both
p \ 0.001). Using a Cox regression model we found that
only changes (D) in diastolic, but not systolic indexes,
correlated with the composite clinical endpoint, with
increments in DEDV20 and DE/DT, single or combined,
greatly increasing risk of heart failure and/or cardiac death
(p = 0.003). Ventricular reverse remodelling, together
with improvement in ventricular filling, rather than
improvements of systolic function, predict clinical prog-
nosis long-term post-CRT.
Keywords Cardiac resynchronization therapy  Heart
failure  Diastolic function
Introduction
Cardiac resynchronization therapy (CRT) improves func-
tional capacity, left ventricular systolic function and sur-
vival in patients with chronic heart failure and left bundle
branch block [1]. Not much, however, is known about the
effects of CRT on diastolic function (DF) in these patients.
This is surprising given that the increase in left ventricular
filling pressure highly correlates with the degree of exer-
cise limitation in patients with chronic heart failure, inde-
pendent of the severity of systolic dysfunction [2].
Furthermore, the few previous studies of the impact of
CRT on DF have presented variable and contrasting results
[3–5].
Thus, the aim of the present study was to assess if and
how CRT impacted DF in systolic heart failure patients. DF
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was assessed using echocardiographic load-dependent as
well as relatively load-independent parameters. In addition,
we analyzed the passive phase of ventricular diastole by the
end-diastolic pressure–volume relationship (EDPVR) using
a single-beat approach that uses noninvasively-estimated
diastolic pressure and volume data [6, 7]. Since CRT can
induce significant ventricular reverse remodelling [8], a
non load-dependent index of EDPVR such as operative
ventricular stiffness (Klv) [9] normalized to end-diastolic
volume (EDV) was also used. Finally, we investigated
potential relations between CRT-induced changes in dia-
stolic parameters and clinical recurrence of heart failure
and/or cardiac death over a follow-up of 3 years.
Methods
Population
One hundred eight five (185) patients with systolic heart
failure (ejection fraction B35 %) and a clinical indication
for CRT were retrospectively identified from our clinic. In
all patients, informed consent had been previously obtained
in accordance with institutional human studies committee
guidelines. From this initial group we excluded patients
with biological or mechanical mitral valves, atrial fibrilla-
tion or high heart rates that precluded a clear separation of
E versus A waves on mitral inflow velocity acquisitions.
No statistical differences in clinical and echocardiographic
parameters between included and excluded patients were
observed, apart from the proportion of AICDs versus
pacemakers, which was higher in the included patients
(p = 0.001) (Table 1).
Thus, our final population (Table 2) included 119
patients (mean age 69.8 ± 8.9 years, 81 % males) suffer-
ing from heart failure due to various aetiologies, who were
candidates for CRT according to latest ESC guidelines
(ejection fraction B35 %, QRS C120 ms and NYHA
functional class II–III despite optimized medical therapy)
[1]. Ischemic cardiomyopathy was defined as a docu-
mented previous myocardial infarction or significant cor-
onary artery disease (luminal narrowing [50 %) at
coronary arteriography. Optimal revascularization had
been performed in these patients. Nonischemic aetiology
was defined only in the presence of angiographically nor-
mal coronary arteries or a negative stress-rest thallium
scan.
Patients were subjected to a transthoracic echocardio-
graphic examination using standard equipment (Vivid 7 or
Vivid E9, GE Medical System, Horten, Norway). Cardiac
cycles were stored in digital format and then subjected to
an off-line analysis using dedicated software (EchoPAC PC
version BT10, GE Healthcare). Patients were imaged
before implantation (29 ± 46 days) and after 4 months
(125 ± 73 days). We evaluated left ventricular end-sys-
tolic and end-diastolic volumes and ejection fraction. In
addition, we acquired extensive evaluation of diastolic
echocardiographic parameters to quantify ventricular
relaxation, filling pressures and left ventricular stiffness by
continuous-Doppler, pulsed and tissue Doppler according
to published guidelines [10]. Furthermore, we quantified
ventricular dyssynchrony using Temporal Uniformity of
Strain (TUS) Index applied to longitudinal strains from 2D
speckle-tracking echocardiographic images. [11].
Patients also underwent a clinical evaluation at baseline
and after 4 months to assess NYHA functional class, to
Table 1 Population’s clinical
characteristics




ejection fraction, ESV end-
systolic volume, NYHA New
York Heart Association
Included patients Excluded patients p value
Patients (n) 119 66
Age (years) 70 ± 9 71 ± 8 0.24
Gender (n, %) Male 96 (81 %) Male 49 (74 %) 0.41
Female 23 (19 %) Female 17 (26 %)
Etiology (n, %) Ischemic 63 (53 %) Ischemic 27 (41 %) 0.16
Nonischemic 56 (47 %) Nonischemic 39 (59 %)
NYHA class 2.7 ± 0.7 2.8 ± 0.7 0.41
Quality of life score 27.3 ± 21.5 32,4 ± 23,4 0.49
Six minute walking test (m) 350 ± 114 302 ± 87 0.12
QRS (ms) 158 ± 25 164 ± 28 0.11
EDV (ml) 195 ± 66 179 ± 59 0.09
ESV (ml) 147 ± 59 134 ± 52 0.10
EF 0.26 ± 0.07 0.26 ± 0.07 0.46
CRT-device (n, %) AICD 109 (92 %) AICD 48 (73 %) 0.001
PaceMaker 10 (8 %) PaceMaker 18 (27 %)
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complete a Minnesota Living with Heart Failure Ques-
tionnaire (MLWHFQ) and perform a 6 min walk test.
During subsequent long-term clinical follow-up
(980 ± 667 days) exacerbations of heart failure causing
hospitalization or activation of ‘‘OPTIVOL’’, available in
39 patients, requiring additional diuretic administration or
death were recorded.
Echocardiographic measurements
Ventricular volumes were calculated in biplane mode using
Simpson’s method applied to images obtained in the apical
4- and 2-chamber views. The degree of mitral regurgitation
was assessed calculating the area of the regurgitant jet on
colour-Doppler images (4- and 2-chambers) and expressed
as a percentage of the left atrium area.
Diastolic function was characterized by classical load-
dependent and relatively load-independent parameters.
Classical load-dependent parameters included: transmitral
early and late diastolic velocity (E and A waves), E-wave
deceleration time (DT), E/A and E/DT ratio assessed using
pulsed Doppler in 4-chamber view. Relatively load-inde-
pendent parameters included: early diastolic mitral annulus
velocity (average of septal-lateral-front and posterior
annulus E0) obtained using pulsed tissue Doppler in the
apical 2- and 4-chamber views. E0 can be considered as a
ventricular relaxation index [10], while the E/E0 ratio rep-
resents a noninvasive estimation of ventricular filling
pressures [12]. Colour M-mode Doppler mitral flow prop-
agation velocity (Vp) was also obtained in a 4-chamber
projection [13]. We were able to calculate this parameter in
53 patients only. We also assessed longitudinal strain rates
during isovolumetric relaxation (IVR) and in the early
phase of diastolic filling [14]. Such parameters were
obtained applying a speckle-tracking algorithm to 4- and
2-chambers apical projections, with the endocardium
manually traced and software automatically drawing epi-
cardial edges in order to identify the region of interest and
to derive a strain curve. The first derivative of the strain
curve presents two diastolic peaks: the first peak (after
aortic valve closure) represents global peak strain rate
during isovolumetric relaxation (SRivr) and is an index of
relaxation rate [15] (Fig. 1). The second peak represents
strain rate during early ventricular filling (SRe) and it is
affected by the final balance between ventricular relaxation
and atrial pressure [14]. Finally we identified the IVR
interval by taking into account the aortic and mitral valve
openings and closings with pulsed wave Doppler. IVR
interval was reported on the strain graph in order to identify
SRivr. E/SRivr ratio was also computed and taken as a
measure of ventricular filling pressures.
Ventricular dyssynchrony was indexed pre and
4 months post CRT by TUS, whereby a time plot of
regional strains, arranged for ventricular location, is sub-
jected to a Fourier analysis. If segments shorten simulta-
neously (synchronously), the plot appears as a straight line,
with power only in the zero-order Fourier term, whereas
regionally clustered dyssynchrony generates an undulating
plot with higher power in the first-order term. TUS index
reflects zero-order relative to first-order plus zero-order
power [11]. We and others have shown that baseline
asynchrony and coincidence between the latest mechanical
activation site and left ventricular lead position predict
favourable prognosis after CRT [11, 16, 17].
Finally we assessed ventricular passive properties
according to a single-beat end-diastolic elastance algorithm
which allows noninvasive estimation of the EDPVR from
EDV and end-diastolic pressure (EDP) [6, 7]. According to
this algorithm the EDPVR of any healthy or sick heart can
be estimated by a nonlinear analytical expression:
EDP = a.EDV^b where EDP is obtained from E/E0
Table 2 Population’s baseline heart rate, aetiology, comorbidity and
therapy
Heart rate (beats/min) 70 ± 14

























Vasculopathy: previous ischemic ictus attack and/or previous carotid
artery thromboendarterectomy and/or previous aortic aneurysmec-
tomy and/or AOCP (chronic obstructive peripheral arteriopathies)
NYHA New York Heart Association, COPD Chronic Obstructive
Pulmonary Disease
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according to the following equation [EDP = 1.91 ?
(1.24E/E0)] [12]. Values obtained in this manner were then
normalized to fixed values of EDP (10, 20, 30 mm Hg) in
order to compare subjects and make comparisons; [EDV10,
EDV20, EDV30 = (EDP/a)
^1/b, with EDP = 10, 20, or
30 mmHg, respectively].
It is recognized, indeed, that there are limitations in
E/E0-based measurements of filling pressures in patients
with conduction abnormalities or undergoing pacing [18].
Thus, passive ventricular properties were also quantified by
Klv, which was determined from DT according to the fol-
lowing equation (Klv = 1.28
exp[-0.008DT]); this approach
has been validated by invasive methods in a group of
comparable cardiomyopathic patients [9]. Values were then
normalized to EDV (Klv/EDV).
Device implantation
All patients received a biventricular pacemaker (10 CRT-P,
109 CRT-D) with lead positions in conventional locations
(right atrium, right ventricle and the coronary sinus).
Implanted devices were: 18 GUIDANT (Renewal), 38
MEDTRONIC (12 Concerto HF, 17 Consulta CRT, 5
Insync, 4 Sentry), 38 SAINT JUDE (20 Atlas HF, 11
Promote Accel, 2 Epic HF, 2 Frontier 2, 2 Unify, 1
Anthem), 9 BIOTRONIK (Lumax HF), 6 SORIN-ELA
(4 Paradyn CRT, 1 Newliving CHF, 1 Ovatio CRT) 10
BOSTON SCIENTIFIC (Cognis). All subjects underwent
echocardiographic-guided atrioventricular optimization
2–3 days after implantation (mean atrioventricular interval
133 ± 30 ms). Interventricular delay was set fixed at 0 ms.
Statistical analysis
Data are expressed as mean ± standard deviation. Differ-
ences between means were assessed using t tests for paired
data. Signed rank tests were used if data were not normally
distributed. Chi square test was used to compare propor-
tions. Univariate and multivariate Cox regression analyses
were used to evaluate the relationship between echocar-
diographic parameters with significant variations pre- and
post-CRT (with the exception of age, gender, aetiology of
cardiac disease and QRS duration) versus recurrence of
heart failure or death (whichever came first) during a
3 year follow-up period. Survival analysis was performed
by Kaplan–Meier survival analysis with significance test-
ing using log-rank statistics and a post hoc Holm–Sidak
test. A two-way repeated-measures ANOVA was finally
used to assess the effects of CRT on time changes in Vp,
with the attribution to responder versus nonresponder
group as a between-patient factor. A p value \0.05 was
considered as statistically significant. Analyses were per-
formed using Sigmaplot (version 12.5 for Windows, Jan-
del; San Rafael, CA) statistical software.
Variability of analysis
Inter-observer variability of echo-Doppler parameters was
determined from 30 randomly selected patients and asses-
sed as absolute mean difference ± the percentage coeffi-
cient of variation (SD/mean). Reproducibility was:
6.6 mL ± 0.93 % for EDV, 0.04 cm/s2 ± 1.1 % for E/DT,
0.92 ± 0.75 % for E/E0, 0.02 s ± 1.2 % for IVR,
SRivr SRe
Fig. 1 Strain rate analysis using spleckle-tracking echocardiography
applied to a 4-chamber view in a patient. The mean derivative curve
of strain (white, dotted line) shows two diastolic peaks. The first peak
represents the global peak strain rate during isovolumetric relaxation
(SRivr), while the second peak represents strain rate during early
ventricular filling (SRe). AVC aortic valve closure valve closure, MVO
mitral valve opening
900 Int J Cardiovasc Imaging (2014) 30:897–905
123
0.06 s-1 ± 9.4 % for SRivrt, 0.09 s
-1 ± 1.55 % for SRe
and 0.15 ± 1.2 % for TUS longitudinal index.
Results
All clinical parameters improved significantly after CRT
(NYHA from 2.7 ± 0.7 to 1.9 ± 0.6, quality of life score
from 27.3 ± 21.5 to 17.6 ± 19.9, 6 min walking test from
350 ± 114 min to 393 ± 107 min, p \ 0.001 for all).
QRS and heart rate decreased (-4.4 ± 20.8 and
-2.4 ± 19.4 %, p = 0.005 and p = 0.01, respectively). At
4 months (Table 3) echocardiographic derived findings
improved as well, showing decreases in ventricular vol-
umes, better ejection fraction and reduced mitral regurgi-
tation. TUS index, measured in the longitudinal axis,
increased after CRT (?12 ± 40 %, p = 0.035, Table 3),
suggesting amelioration of baseline dyssynchrony.
Load-dependent left ventricular filling parameters
improved too: E wave velocity decreased (-9.8 ±
28.6 cm/s, p \ 0.001), as did the E/A ratio (-0.4 ± 1.2,
p = 0.045). Due to an increment in DT, the E/DT ratio
decreased significantly (-0.09 ± 0.33 cm/s2, p = 0.01)
suggesting improved filling characteristics.
Noninvasive left ventricular filling pressure measure-
ments tended to decrease, but insignificantly (E/E0
-1.4 ± 9.9 cm/s; SRe ?0.0026 ± 0.22 s
-1; E/SRivr
-592 ± 3,384; estimated EDP from 22.4 ± 12.6 mmHg
to 20.1 ± 12.9 mmHg; ns for all). Furthermore, no sig-
nificant changes could be detected for the diastolic relax-
ation indices E0 and SRivr (Table 3). IVR increased post-
CRT (?0.014 ± 0.05 s, p = 0.014).
As far as the diastolic passive properties were concerned
(Fig. 2), at 4 months follow-up there were significant
(p \ 0.05) reductions in EDV10 EDV20 and EDV30, with no
change in slope coefficients of EDPVR, consistent with an
unmodified Klv/EDV. As shown in the figure and Table 3,
there was a significant shift of the estimated EDPVR to
smaller volumes, indicative of reverse remodeling.
Clinical outcomes
Follow-up data, obtained from hospital records and/or
telephone interviews with patients or their relatives, were
Table 3 Echocardiographic parameters before and 4 months after
CRT
Basal 4 months p value
End-systolic
volume (ml)
147 ± 59 125 ± 52 \0.001
End-diastolic
volume (ml)
195 ± 66 178 ± 59 \0.001
Ejection
fraction
0.26 ± 0.07 0.32 ± 0.09 \0.001
MI area/left
atrium area
0.17 ± 0.15 0.12 ± 0.13 \0.001
Dyssyncrony
(TUS index)
0.59 ± 0.15 0.62 ± 0.15 0.035
E wave (cm/s) 75 ± 30 65 ± 26 \0.001
A wave (cm/s) 69 ± 27 70 ± 23 0.85
E/A 1.41 ± 1.16 1.15 ± 0.93 0.045
DT (ms) 190 ± 78 217 ± 90 0.038
E/DT (cm/s2) 0.48 ± 0.29 0.39 ± 0.31 0.01
IVR (s) 0.125 ± 0.05 0.132 ± 0.05 0.014
E0 (cm/s) 5.29 ± 1.81 5.39 ± 1.84 0.90
SRivr (s
-1) 0.09 ± 0.15 0.11 ± 0.16 0.44
E/E0 16.7 ± 10.5 14.8 ± 10.7 0.23
SR e (s-1) 0.369 ± 0.176 0.361 ± 0.171 0.37
E/SRivr 548 ± 2,895 165 ± 1,837 0.55
EDV10 (ml) 173.9 ± 62.6 163.3 ± 61.7 0.043
EDV20 (ml) 194.2 ± 70.0 181.2 ± 65.0 0.017
EDV30 (ml) 207.5 ± 75.5 192.9 ± 68.6 0.013
a Coefficent
EDPVR
2.7E-0.8 ± 3E-0.7 6E-0.9 ± 4E-0.8 0.10
b Coefficent
EDPVR




0.0017 ± 0.0009 0.0016 ± 0.0010 0.47
CRT cardiac resynchronization therapy, DT deceleration time, ED-
PVR end-diastolic pressure–volume curve, EDV10–20–30 end-diastolic
ventricular volume at 10–20–30 filling pressures, IVR isovolumetric
relaxation time, Klv operative ventricular stiffness, MI mitral insuffi-
ciency, SRe strain rate E, SRivr isovolumetric strain rate
Fig. 2 CRT-induced effects on ventricular diastolic volumes
(mean ± SE) at comparable filling pressures (10–20–30 mmHg).
Graph suggests a CRT-mediated leftward shifting towards a smaller
equilibrium volume with no change in EDPVR slope, compatible with
a reverse remodeling effect
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available for all but 1 subject, who was lost at follow-up.
Three more patients died for unknown reasons before any
information about their clinical status prior to death could
be acquired and were thus excluded from survival analysis
There were 44 patients that reached the end-point (13
deaths, 26 patients with heart failure hospitalizations, 5
patients with ‘‘OPTIVOL’’ alarm activations followed by
additional diuretic administration).
According to the univariate results (accepted level
p \ 0.1) of the Cox regression analysis DE/DT
(p = 0.013), taken as a cumulative descriptor of ventricu-
lar filling, DEDV20 (p = 0.021), expression of the amount
of CRT-induced ventricular reverse remodeling [19], and
changes in end-systolic volume (DESV, p = 0.002), used
as an index of ventricular performance, were included, as
continuous covariates expressed as a percent change, in the
multivariate analysis. Gender and etiology of ventricular
dysfunction (ischemic/nonischemic) were also included as
categorical covariates together with age and duration of
QRS, gender acting as a stratum [20]. The analysis showed
that progressive ventricular remodeling (DEDV20%
p = 0.053) and worsening in left ventricular filling char-
acteristics (DE/DT % p = 0.053) predicted heart failure
exacerbations or death during the follow-up. Patients’ age
(p = 0.015) and ischemic etiology (p = 0.013) contributed
too. There was no significant contribution from DESV %
or QRS duration (p = 0.609 and p = 0.682, respectively).
In order to confirm that DEDV20 and DE/DT (both
measurements available in 84 patients) affected survival
after CRT, we performed a Kaplan–Mayer analysis clas-
sifying the CRT population on a DEDV20 [-7.47 ml
(-4.34 % relative to pre CRT)] plus an DE/DT [-0.05 cm/s2
(-18 % relative to pre CRT)] entire population median
basis. Thus, 3 groups were created according to the values
of DEDV20 and DE/DT compared to the related medians
(group 1, n = 22: DEDV20 \5 % and DE/DT \18 %;
group 2, n = 41: DEDV20 \5 % and DE/DT [18 % or
DEDV20 [5 % and DE/DT \18 %; group 3, n = 21:
DEDV20 [5 % and DE/DT [18 %).
Event-free survival curves for the three groups, shown in
Fig. 3, were significantly different (log-rank test
p = 0.001). Group 3 event-free survival was half of that of
group 1 at the end of follow-up. Furthermore, group 3
event-free survival rapidly decreased in the first 500 days
after CRT. In contrast, group 1 event-free survival was
maintained around 90 % until the end of the observation
period. The difference, based on a post hoc Holm–Sidak
test was statistically significant (p \ 0.006). Group 2
exhibited an intermediate trend, with improved event-free
survival as compared with group 3 (p \ 0.03), but worse
relative to group 1, although not at a significant level
(p = 0.113, ns). The results could not be explained by
differences in the drug distribution among the three groups.
The percentage of patients treated with beta-blockers (85,
Fig. 3 Survival curves obtained dividing patients into three groups
according to values of DEDV20 and DE/DT compared to the related
medians. Group 1: DEDV20 \5 % and DE/DT \18 %, group 2:
DEDV20 \5 % and DE/DT [18 % or DEDV20 [5 % and DE/DT
\18 %, group 3 DEDV20[5 % and DE/DT[18 %. Group 3 survival
is half of that of group 1 at the end of follow-up. Furthermore, group 3
survival rapidly decreases in the first 500 days after CRT. In group 1
instead, survival from heart failure and cardiac death is maintained
around 90 % until the end of the observation. The difference is
statistically significant (p \ 0.006). Group 2 exhibits an intermediate
trend, with an improved survival as compared with group 3 (p \ 0.03)
but worse than group 1, although not at a significant level (p = 0.113,
ns)
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75, 68 %), diuretics (76, 73, 77 %) and ACE inhibitors/
AT1 antagonists (86, 85, 86 %) was not dissimilar among
the 3 groups (p = 0.995).
Discussion
Our study demonstrates that CRT does not significantly
affect relaxation phase (E0 and SRivr), nor filling pressures
(E/E0 and E/SRivr) in patients affected by dilated cardio-
myopathy and systolic heart failure at 4-month follow-up.
CRT, however, induces left ventricular reverse remodel-
ling, resulting in a smaller ventricle with improved filling
characteristics. Both dyssynchrony and systolic function
improve after CRT, as demonstrated by TUS index and
ejection fraction increments versus systolic volume decre-
ments, but such changes do not seem to influence patients’
outcome long-term in a significant way.
Previous studies have demonstrated that CRT improves
DF only in patients with an associated improvement in
systolic function [3, 4]. However, data regarding CRT
effects on diastole are controversial. Waggoner et al. [4]
evaluated DF in a cohort of 50 heart failure patients
receiving CRT using conventional echocardiographic
measurements before and after 4-month follow-up. They
defined as ‘‘responders’’ patients with an[5 % increase in
ejection fraction at 4-month. Transmitral parameters (E,
E/A, DT) and E/E0 ratio showed significant improvements
only in responders. E0, an indirect index of relaxation, did
not change in either group. The authors concluded that
CRT exerts a beneficial effect on LV filling pressures but
does not affect relaxation properties.
Jansen et al. [3] evaluated DF after up to 12 months of
CRT. Both diastolic load-dependent and relatively load-
independent measurements (respectively E, E/A, DT, E0
and E/E0) were significantly improved only in responders,
defined as patients with a reduction [15 % in LV systolic
volume at 12-month follow-up. In contrast to Waggoner
et al., they concluded that reverse remodelling induced by
CRT was associated with an improvement in both relaxa-
tion and filling pressures. Along the same line of thinking,
Aksoy et al. [21] documented an improvement in filling
pressures, estimated using the E/E0 ratio, only in responders
defined as patients with a reduction C10 % in LV systolic
volume at 6-month follow-up after CRT.
Porciani et al. [22] classified 65 patients according to the
transmitral profile in restrictive and non restrictive filling
patterns (25 vs. 40 patients). At 12-month follow-up after
CRT implantation E/A ratio increased and DT decreased in
the non-restrictive filling pattern group. In the restrictive
group, instead, 13 patients showed a reduction in E/A and
an increase in DT, while in the remaining patients the
restrictive filling pattern did not vary. All cause mortality
rate was 5 % in non restrictive filling pattern group, 15 %
in patients with reversible restrictive filling pattern and
42 % in patients with persistent restrictive filling profile.
These authors concluded that CRT improves DF in a
considerable number of patients with filling restriction at
implantation, but persistence of the restriction pattern after
CRT is associated with worse outcome.
Shanks et al. [15] evaluated DF using speckle-tracking
imaging, in addition to conventional methods. One hundred
eighty-eight heart failure patients were evaluated before
CRT implantation and at 6-month follow-up. Responders
were defined as patients with a decrease in LV systolic
volume C15 % 6 months after implantation. Among con-
ventional echocardiographic parameters only DT showed
an improvement in both responders and non responders.
All the remaining parameters, such as E, E/A, E0 and E/E0,
did not show any significant changes. SRivr and E/SRivr
ratios, obtained with speckle-tracking analysis, improved
only in responders, suggesting that CRT has beneficial
effects on both relaxation and filling pressures.
Retracing Shanks’ study, our aim was to evaluate DF in
patients with dilated cardiomyopathy and to verify if and
how improvements after CRT, if any, affect patients’ out-
comes. In line with previous studies, we documented an
improvement in transmitral flow parameters, which are
load-dependent. In contrast with data in literature, how-
ever, neither relaxation parameters (E0 and SRivr) nor
indirect filling pressure descriptors (E/E0 and E/SRivr)
showed statistically significant improvements. Only IVR
increased significantly.
As mentioned before, ventricular diastolic relaxation is
influenced by both myocardial inactivation and asynchrony
[23]. Since asynchrony decreased after CRT, as docu-
mented by the improvements in TUS index, it is difficult to
substantiate why this improvement does not affect relaxa-
tion parameters. A first interpretation may be that although
CRT reduces asynchrony, it does not modify intracellular
factors (such as SERCA quantity) involved in the process
of pressure decay during IVR, in contrast with other
experimental studies [24]. This conclusion is consistent
with prior animal studies showing no change in the rate of
relaxation despite large changes in the degree of ventricular
synchrony [25]. In a more realistic scenario the modifica-
tions induced by CRT are minor and not easily inferable
from noninvasive indices, with limited reliability in quan-
tification of ventricular relaxation.
Effects of CRT on ventricular passive properties
In contrast to previous noninvasive studies, we evaluated
ventricular passive properties and how they were affected
by CRT. After having computed EDV10, EDV20 EDV30
and Klv/EDV we can conclude that CRT induces reverse
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123
remodelling with no change in slope of EDPVR (Table 3).
Such shift towards a smaller equilibrium volume, with no
significant change in diastolic curve profile, would sub-
stantiate previous invasive studies performed in a smaller
study reporting a simple reduction in ventricular volume
post-CRT, with no change in stiffness [26].
In our study, the reverse remodelling effect of CRT was
associated with no statistically significant change in filling
pressures, but with an improvement in the filling profile
that seems to have prognostic relevance. Survival analysis,
in fact, proves that patients with reduction in DE/DT
greater than 18 % post-CRT exhibit better survival based
on the composite clinical endpoint of worsening heart
failure or cardiac death (Fig. 3). The combination of
improved filling and reverse remodelling could possibly be
related to a reduction in convective deceleration due to
decrement in turbulent forces associated with cardiomegaly
[27, 28]. Unfortunately, there was no difference in Vp
(available before and after CRT in 53 patients only)
between the two groups created by dividing the population
according to DEDV20 \[5 %, although overall Vp
increased in both groups after CRT (?4.9 ± 12.8
vs. ? 5.8 ± 17.9 cm/s, interaction p = ns). There was,
instead, a significant interaction (p = 0.002) between time
changes in Vp and CRT when DE/DT\[18 % was used as
a grouping criterion (-2.4 ± 15.2 vs. ?10.3 ± 11.2 cm/s).
Such findings are compatible with ventricular overfilling in
patients doing badly after CRT and do not conflict with the
hypothesis of a modest increment in apical gradient in
those improving after CRT [29, 30].
Limitations
Operator-dependency of all the measured echocardio-
graphic measurements is an unavoidable limitation. In
practical terms, this limits the reliability of the data
acquisition process. In this regard NMR data would have
been more reliable, but difficult to obtain in this patients’
population.
The experimental data were partly biased by not cal-
culating SRivr in those patients with an inadequate apical
4-chamber and/or 2-chamber view. Thirdly, DF was not
evaluated via invasive measurements of pressure and vol-
ume but exclusively inferred from echocardiographic
parameters. It should be considered, however, that the
estimate of EDPVR from a single beat has demonstrated a
good correlation with EDPVR measured with invasive
techniques, as reported by Klotz et al. [6, 7]. Thus,
EDV10–20–30 can be considered as a reliable parameter for
describing the ventricular passive properties and can be
used to describe the process of reverse remodeling after
CRT as long as the original input is correct. Given the
limitations of E/E0-based measurements of filling pressures
in patients with conduction abnormalities or undergoing
pacing [18], we used Klv/EDV as another parameter,
beyond single-beat EDPVR, in order to confirm the chan-
ges in ventricular characteristics post-CRT.
Another limitation to be taken into consideration is the
relatively small sample size and short follow-up time at
which echocardiographic data were obtained. Expansion of
the patients’ population and another echocardiographic
assessment, after 6 or 12 months, would have allowed
verification of the positive trend in the filling profile and
echocardiographic parameters of relaxation. In this regard
it has to be underlined that the use of the E–E0 time
interval, instead of the indexes here considered, could have
been better descriptor of the relaxation behavior pre/post-
CRT [31]. Unfortunately, in our data, the nonsimultaneous
acquisition of the 2 peaks precluded any reliable time-
interval computation [32].
Also the time of first evaluation and diagnosis of heart
failure and patient’s comorbidity (Table 2) may be of
importance in the recurrence of hospitalization and death.
So we decided to include diabetes and/or renal failure
(defined as creatinine clearance\60 ml/min) as categorical
covariates in the Cox analysis. There were no substantial
changes in the final results, with age (p = 0.017), ischemic
etiology (p = 0.007) and worsening in LV filling charac-
teristics (DE/DT% p = 0.033) predicting HF exacerbations
or death during follow-up. The statistical weight of
DEDV20% decreased slightly (p = 0.068), There was no
contribution at all from DESV% (p = 0.658), QRS dura-
tion (p = 0.533) and presence of diabetes and/or chronic
renal insufficiency (p = 0.138).
Conclusions
Our study demonstrates that CRT improves systolic func-
tion and ventricular dyssynchrony and in particular it
positively affects DF through a reverse remodeling process
due to a left shifting towards a smaller equilibrium volume,
with no change in the slope of EDPVR. Such evolution is
associated with a favorable impact on the filling profile,
although direct indexes of improved active relaxation are
not significantly affected.
Finally, short-term changes in DF, together with ven-
tricular volume shrinkage, rather than improvement in
systolic function, predict clinical prognosis long-term post-
CRT. Such a combination (improved filling coupled with
reverse remodelling), rather than amelioration in systolic
pump performance, seems to modulate long-term follow-
up in these patients.
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